Cingulate Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Biotechnology

Other Names/Subsidiaries

  • Cingulate Therapeutics, LLC
See more in Biomedtracker

Latest on Cingulate Inc.

Scrip

Cingulate Sets Sights On $18bn ADHD Market With Precision Timed-Release Approach

 
• By Ayisha Sharma

Cingulate Inc. was founded in 2012 with the goal of addressing the unmet needs of patients with attention-deficit hyperactivity disorder (ADHD), a neurobehavioral disorder characterized by difficulty

Scrip

Finance Watch: Five More Small IPOs Squeeze Through The US Window

 
• By Mandy Jackson

The biopharmaceutical initial public offering pace has picked back up in the US again with five new offerings so far in December, but all of the IPOs were launched by firms that raised relatively smal

Scrip

Venture Funding Deals: Alector, Ascentage, Gossamer And Compass Lead Summer Rounds

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma